Lhch Header
Liverpool Heart and Chest Hospital, Thomas Drive, L14 3PE
Switchboard: 0151 600 1616

Trans Catheter Aortic Valve Implantation (TAVI)

Liverpool Heart and Chest Hospital was one of the first NHS hospitals in the UK to provide a Transcatheter Aortic Valve Implantation (TAVI) service.

Aortic stenosis (narrowing of the outflow valve of the heart) is the commonest valve disorder in the UK. It can be the cause of severe cardiac symptoms and even sudden death when severe. Conventionally open heart surgery is used to replace the valve.

Transcatheter aortic valve implantation (TAVI) allows the aortic valve to be replaced without the need for open-heart surgery, and is therefore a good option for patients in whom the risks of open-heart surgery are unacceptably high.

There is a well-established TAVI program at LHCH, which was launched in September 2008, using the Edwards Sapein device (see TAVI overview). Patients are carefully assessed and discussed at a multidisciplinary meeting before being considered for TAVI.

 A high volume of TAVI procedures have now been performed at LHCH with excellent results.

LHCH was the first cardiac unit in the UK to have a purpose built state-of-the-art Hybrid Theatre that allows our team to perform  TAVI procedures in the most desirable clinical environment. 


The team comprises both Aortic Heart Surgeons and Cardiologists:

TAVI is a highly specialist alternative to surgical valve replacement for people whose aortic stenosis is causing symptoms which, if severe, can be life limiting and life threatening. 

Because the procedure is performed in a minimally invasive way, TAVI is particularly used as an intervention to help patients with the worst prognosis where conventional “open heart” aortic valve replacement would carry a very high a risk. 

TAVI Resources

Our TAVI team hosted a dedicated TAVI educational event in 2013.

The aim of this meeting was to review the current state-of-art management of patients with severe, degenerative aortic stenosis and focus on which patients should be considered for TAVI and when/how to refer them on to us.

On the day, we reviewed the evidence base for TAVI, reflected upon our TAVI outcomes in line with national/international data and gave an insight in to our MDT process.

Degenerative aortic valve stenosis is the most common form of valvular heart disease in the developed world and yet so many patients are not even considered for any interventional therapy.

The lives of our patients have been utterly transformed by the TAVI procedure and we felt that it was essential that you were fully informed about our TAVI programme, our results so far and our plans for the future.